Deutsche Bank
IONS icon

Deutsche Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Deutsche Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-780
Closed -$48K – 5544
2014
Q4 		$48K Buy
780
+450
+136% +$22.2K ﹤0.01% 5147
2014
Q3 		$12K Sell
330
-350
-51% -$12.4K ﹤0.01% 5346
2014
Q2 		$23K Buy
+680
New +$21.4K ﹤0.01% 5267
2014
Q1 		– Sell
-1,500
Closed -$21K – 5687
2013
Q4 		$21K Hold
1,500
– – ﹤0.01% 4713
2013
Q3 		$19K Buy
1,500
+1,250
+500% +$37.3K ﹤0.01% 4906
2013
Q2 		$2K Buy
+250
New +$5.32K ﹤0.01% 5163

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Deutsche Bank's IONS Position: Q2 2026 in Review

Deutsche Bank increased its Ionis Pharmaceuticals (IONS) stake by 6.1% in Q2 2026, buying an estimated $732K and bringing the position to 169,614 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Deutsche Bank first reported a position in IONS in Q2 2013 and has held it in 53 quarters since. The position peaked at $68M in Q3 2017. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Deutsche Bank held 169,614 shares of Ionis Pharmaceuticals worth $13.4M as of Q2 2026.
  • Deutsche Bank bought 9,723 Ionis Pharmaceuticals shares in Q2 2026, an estimated $732K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #967 holding.
  • Deutsche Bank first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Ionis Pharmaceuticals position peaked at $68M in Q3 2017.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.